As of Mar 24
| +3.52 / +1.06%|
The 22 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 397.50, with a high estimate of 444.00 and a low estimate of 270.00. The median estimate represents a +18.25% increase from the last price of 336.16.
The current consensus among 25 polled investment analysts is to Buy stock in Eli Lilly and Co. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.